Is an R & amp;D Race Driving the Surgical Robotics Market?

Robotic-assisted surgery has emerged with an attempt to overcome the limitations of traditional minimally invasive surgical procedures. With increasing competition, the way to gain market share in this quickly growing market is with innovative technology. This means R&D is at the forefront of this market, driving adoption, expanding applications, and leading to a market that will more than double in size by 2025. It’s been a steady trajectory since the first medical robot, Arthrobot, was developed in Canada in 1983 for use during orthopedic procedures1. Then, the first robotic-assisted procedure, neurosurgical biopsy, was performed with the PUMA 560 platform in 19852. Intuitive Surgical's da Vinci platform, the most prominent representative of the robotic-assisted surgery market today, first received FDA approval in 2000. Since then, a significant number of market players have entered the lucrative robotic-assisted market, further expanding the applications. A number of startups and large, well-established corporations are currently involved in R&D activities and are planning to enter the robotic-assisted surgery market in the near future. The total robotic-assisted surgery market in the United States is projected to exhibit a nearly four-fold increase from 2015 to 2025 and nearly two-and-a-half-fold increase from 2018 to 2025. This impressive growth is expected to be primarily driven by increasing adoption of robotic surgery for spinal and total...
Source: MDDI - Category: Medical Devices Authors: Tags: R & D Orthopedics Source Type: news

Related Links:

Publication date: Available online 24 May 2019Source: Annals of Medicine and SurgeryAuthor(s): Akio Kanda, Kazuo Kaneko, Osamu Obayashi, Atsuhiko Mogami, Itaru MorohashiAbstractHemophilia A is a congenital bleeding disorder caused by an X-linked hereditary pattern. Female hemophilia A carriers are usually asymptomatic, although some have far lower levels of clotting factor because more X chromosomes with the normal gene are switched off, a phenomenon referred to as "lyonization.” During a medical checkup at our hospital, a 56-year-old Japanese woman with coxalgia was also diagnosed as an obligate hemophilia A ca...
Source: Annals of Medicine and Surgery - Category: General Medicine Source Type: research
Publication date: Available online 24 May 2019Source: Journal of EthnopharmacologyAuthor(s): Jingjing Zhou, JianXiu Zhai, Wenlin Zheng, Na Han, Zhihui Liu, Guanghui Lv, Xiaojiao Zheng, Sheng Chang, Jun YinAbstractEthnopharmacological relevanceTraditional Chinese medicine Celastrus orbiculatus Thunb (C. orbiculatus) with peel and seeds is mainly composed of flavonoids, sesquiterpenes and tripenes. According to the Traditional Chinese medicine standard of Liaoning province (2009), it has been long used to invigorate blood circulation.Aim of the studyTo identify the antithrombus fraction and components of C. orbiculatus, and ...
Source: Journal of Ethnopharmacology - Category: Drugs & Pharmacology Source Type: research
BACKGROUND Topical application, oral, and IV injection of tranexamic acid (TXA) have been used to reduce surgical bleeding. OBJECTIVE To evaluate the safety and efficacy of TXA injected subcutaneously to reduce bleeding during dermatologic surgery. METHODS In this double-blinded, placebo-controlled, randomized prospective study, 131 patients were randomized to subcutaneous injection of lidocaine 2% diluted 1:1 with either saline (placebo) or TXA 100 mg/1 mL before surgery. Before the second stage or closure, size measurements of bloodstain impregnation on Telfa and surgical wound size were recorded and analyzed usi...
Source: Dermatologic Surgery - Category: Dermatology Tags: Original Article Source Type: research
Authors: Dhamane AD, Baker CL, Rajpura J, Mardekian J, Dina O, Russ C, Rosenblatt L, Lingohr-Smith M, Lin J Abstract Objective: To compare the risk of hospitalization and costs associated with major bleeding (MB) or stroke/systemic embolism (SE) among elderly patients with nonvalvular atrial fibrillation (NVAF) who initiated apixaban then switched to another oral anticoagulant (OAC) vs. those who continued with apixaban treatment. Methods: NVAF patients (≥65 years) initiating apixaban were identified from the Humana database (1/1/2013-9/30/2017) and grouped into Switcher and Continuer cohorts. For Switchers, the...
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research
Conclusions: Trans-apical off-pump MV repair with the NeoChord system is a safe, minimally invasive procedure, with few minor complications. In well-selected candidates it provides successful treatment of degenerative MR. Results are anatomy dependent, so preoperative patient selection is crucial. PMID: 31119000 [PubMed]
Source: Videosurgery and Other Miniinvasive Techniques - Category: Surgery Tags: Wideochir Inne Tech Maloinwazyjne Source Type: research
Conclusions: We believe that uniportal VATS is a safe, feasible, and effective technique for selected bronchiectasis patients. PMID: 31118998 [PubMed]
Source: Videosurgery and Other Miniinvasive Techniques - Category: Surgery Tags: Wideochir Inne Tech Maloinwazyjne Source Type: research
Conclusions: Laparoscopic total mesorectal excision using the intersphincteric approach through the sacrococcygeal incision is feasible for treating patients with a contracted pelvis and super-low rectal carcinoma. PMID: 31118985 [PubMed]
Source: Videosurgery and Other Miniinvasive Techniques - Category: Surgery Tags: Wideochir Inne Tech Maloinwazyjne Source Type: research
Conclusions: The LSEGDS is a safe and effective procedure for management of cirrhotic portal hypertension, especially in patients with visible paraesophageal veins. PMID: 31118982 [PubMed]
Source: Videosurgery and Other Miniinvasive Techniques - Category: Surgery Tags: Wideochir Inne Tech Maloinwazyjne Source Type: research
In this study, we evaluated the incidence of postoperative bleeding, hematoma formation, and wound dehiscence after perioperative aspirin ingestion before foot and ankle surgery. The medical records of 379 patients treated over a 3-year period were reviewed. Patient demographics, surgical procedures, affected limbs (right foot versus left foot), anatomical surgical sites (forefoot, midfoot, and rearfoot), and week 2 surgical site inspection data were recorded. Mean patient age was 60.12 (range 21 to 81) years, and the overall wound complication rate was 0.80%. The patients were classified into 2 groups: those who took 81 m...
Source: The Journal of Foot and Ankle Surgery - Category: Orthopaedics Source Type: research
Caplacizumab-yhdp (Cablivi) is the first drug specifically indicated for acquired thrombotic thrombocytopenic purpura, a rare and potentially life-threatening blood clotting disorder. It is prescribed in combination with plasmapheresis and immunosuppressive therapy.The drug carries a warning that severe bleeding can occur with use, although the most common adverse effects are headache and minor bleeding from the nose or gums.Caplacizumab-yhdp is given initially as an iv bolus and then as a subcutaneous injection along with plasmapheresis.
Source: AJN - Category: Nursing Tags: Drug Watch Source Type: research
More News: Biology | Bleeding | Brain | Canada Health | China Health | Craniofacial Surgery | Endoscopy | History of Medicine | Israel Health | Laser Surgery | Medical Devices | Neurology | Neurosurgery | Orthopaedics | Singapore Health | South Korea Health | Strategic Planning | Switzerland Health | USA Health